88 related articles for article (PubMed ID: 24238123)
1. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.
Birnbaum DJ; Gaujoux S; Cherif R; Dokmak S; Fuks D; Couvelard A; Vullierme MP; Ronot M; Ruszniewski P; Belghiti J; Sauvanet A
Surgery; 2014 Jan; 155(1):13-21. PubMed ID: 24238123
[TBL] [Abstract][Full Text] [Related]
2. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
3. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
[TBL] [Abstract][Full Text] [Related]
4. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
[TBL] [Abstract][Full Text] [Related]
5. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
[TBL] [Abstract][Full Text] [Related]
6. Parenchyma-sparing resections for pancreatic neuroendocrine tumors.
Cherif R; Gaujoux S; Couvelard A; Dokmak S; Vuillerme MP; Ruszniewski P; Belghiti J; Sauvanet A
J Gastrointest Surg; 2012 Nov; 16(11):2045-55. PubMed ID: 22911124
[TBL] [Abstract][Full Text] [Related]
7. Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival.
Toste PA; Kadera BE; Tatishchev SF; Dawson DW; Clerkin BM; Muthusamy R; Watson R; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Gastrointest Surg; 2013 Dec; 17(12):2105-13. PubMed ID: 24101447
[TBL] [Abstract][Full Text] [Related]
8. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.
DiNorcia J; Lee MK; Reavey PL; Genkinger JM; Lee JA; Schrope BA; Chabot JA; Allendorf JD
J Gastrointest Surg; 2010 Oct; 14(10):1536-46. PubMed ID: 20824378
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.
Sharpe SM; In H; Winchester DJ; Talamonti MS; Baker MS
J Gastrointest Surg; 2015 Jan; 19(1):117-23; discussion 123. PubMed ID: 25155459
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.
Jilesen AP; van Eijck CH; in't Hof KH; van Dieren S; Gouma DJ; van Dijkum EJ
World J Surg; 2016 Mar; 40(3):729-48. PubMed ID: 26661846
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients.
Bilimoria KY; Tomlinson JS; Merkow RP; Stewart AK; Ko CY; Talamonti MS; Bentrem DJ
J Gastrointest Surg; 2007 Nov; 11(11):1460-7; discussion 1467-9. PubMed ID: 17846854
[TBL] [Abstract][Full Text] [Related]
12. Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Barenboim A; Lahat G; Nachmany I; Nakache R; Goykhman Y; Geva R; Osher E; Scapa E; Wolf I; Orbach L; Brazowski E; Isakov O; Klausner JM; Lubezky N
J Gastrointest Surg; 2020 Jun; 24(6):1366-1374. PubMed ID: 31197692
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.
Finkelstein P; Sharma R; Picado O; Gadde R; Stuart H; Ripat C; Livingstone AS; Sleeman D; Merchant N; Yakoub D
J Gastrointest Surg; 2017 May; 21(5):855-866. PubMed ID: 28255853
[TBL] [Abstract][Full Text] [Related]
14. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.
Abdalla TSA; Bolm L; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Bronsert P; Litkevych S; Honselmann KC; Braun R; Gebauer J; Hummel R; Keck T; Wellner UF; Deichmann S
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275882
[TBL] [Abstract][Full Text] [Related]
15. Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?
Polette D; Busquets J; Secanella Medayo L; Sorribas Grifell M; Peláez Serra N; Uribe C; Martinez-Carnicero L; Salord Vila S; Guerrero F; Vercher-Conejero JL; Teulé A; Fabregat J
Rev Esp Enferm Dig; 2024 Apr; 116(4):209-215. PubMed ID: 38010101
[TBL] [Abstract][Full Text] [Related]
16. Clinical Prognosticators of Metastatic Potential in Patients with Small Pancreatic Neuroendocrine Tumors.
Vega EA; Kutlu OC; Alarcon SV; Salehi O; Kazakova V; Kozyreva O; Chan JA; Conrad C
J Gastrointest Surg; 2021 Oct; 25(10):2593-2599. PubMed ID: 33660111
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
Arya S; Ventin M; Nebbia M; Fernandez-Del Castillo C; Lionetto G; Qadan M; Lillemoe KD; Deshpande V; Catalano OA; Thiele EA; Ferrone CR
Ann Surg Oncol; 2023 Nov; 30(12):7748-7755. PubMed ID: 37648887
[TBL] [Abstract][Full Text] [Related]
18. Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review.
Clarke CN; Ward E; Henry V; Nimmer K; Phan A; Evans DB
Ann Surg Oncol; 2024 Apr; ():. PubMed ID: 38652199
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Link Between Pancreatic Neuroendocrine Tumors and Depression: A Case Study.
Villa NAE; Fiore GMP; Espiridion ED
Cureus; 2023 Aug; 15(8):e44363. PubMed ID: 37779774
[TBL] [Abstract][Full Text] [Related]
20. Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis.
Ricci C; Casadei R; Taffurelli G; Pacilio CA; Campana D; Ambrosini V; Donatella S; Minni F
Ann Surg Oncol; 2017 Sep; 24(9):2603-2610. PubMed ID: 28681158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
